These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27130664)

  • 1. The phosphorylation-specific association of STMN1 with GRP78 promotes breast cancer metastasis.
    Kuang XY; Jiang HS; Li K; Zheng YZ; Liu YR; Qiao F; Li S; Hu X; Shao ZM
    Cancer Lett; 2016 Jul; 377(1):87-96. PubMed ID: 27130664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients.
    Kuang XY; Chen L; Zhang ZJ; Liu YR; Zheng YZ; Ling H; Qiao F; Li S; Hu X; Shao ZM
    Oncotarget; 2015 Sep; 6(26):22227-38. PubMed ID: 26087399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic role of a phospho-Stathmin 1 signature in breast cancer treated with neoadjuvant chemotherapy.
    Xie Z; Zhen T; Lin Y; Shao N; Kuang X
    Gland Surg; 2022 Nov; 11(11):1808-1816. PubMed ID: 36518803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between High Expression of Phosphorylated-STMN1 and Mesenchymal Marker Expression and Cancer Stemness in Breast Cancer.
    Handa T; Yokobori T; Obayashi S; Fujii T; Shirabe K; Oyama T
    Anticancer Res; 2023 Dec; 43(12):5341-5348. PubMed ID: 38030185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma.
    Zhao Y; Qiao W; Wang X; Yin H; Cui J; Cui Y; Chen X; Hu J; Lu H; Meng Q; Wang Y; Cai L
    Oncotarget; 2016 Dec; 7(50):82972-82984. PubMed ID: 27764818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma.
    He X; Liao Y; Lu W; Xu G; Tong H; Ke J; Wan X
    Tumour Biol; 2016 Jul; 37(7):9951-8. PubMed ID: 26815505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
    Obayashi S; Horiguchi J; Higuchi T; Katayama A; Handa T; Altan B; Bai T; Bao P; Bao H; Yokobori T; Nishiyama M; Oyama T; Kuwano H
    Int J Oncol; 2017 Sep; 51(3):781-790. PubMed ID: 28766688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer.
    Hemdan T; Lindén M; Lind SB; Namuduri AV; Sjöstedt E; de Ståhl TD; Asplund A; Malmström PU; Segersten U
    Br J Cancer; 2014 Sep; 111(6):1180-7. PubMed ID: 25072257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
    Bao P; Yokobori T; Altan B; Iijima M; Azuma Y; Onozato R; Yajima T; Watanabe A; Mogi A; Shimizu K; Nagashima T; Ohtaki Y; Obayashi K; Nakazawa S; Bai T; Kawabata-Iwakawa R; Asao T; Kaira K; Nishiyama M; Kuwano H
    Ann Surg Oncol; 2017 Dec; 24(13):4017-4024. PubMed ID: 28933054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
    Zhao C; Li H; Wang L; Sun W
    Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STMN1 Promotes Tumor Metastasis in Non-small Cell Lung Cancer Through Microtubule-dependent And Nonmicrotubule-dependent Pathways.
    Zeng L; Lyu X; Yuan J; Chen Y; Wen H; Zhang L; Shi J; Liu B; Li W; Yang S
    Int J Biol Sci; 2024; 20(4):1509-1527. PubMed ID: 38385074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer.
    Nie W; Xu MD; Gan L; Huang H; Xiu Q; Li B
    Lab Invest; 2015 Jan; 95(1):56-64. PubMed ID: 25384122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
    Watanabe A; Suzuki H; Yokobori T; Tsukagoshi M; Altan B; Kubo N; Suzuki S; Araki K; Wada S; Kashiwabara K; Hosouchi Y; Kuwano H
    Cancer Sci; 2014 Jun; 105(6):690-6. PubMed ID: 24708177
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Imura S; Yamada S; Saito YU; Iwahashi S; Arakawa Y; Ikemoto T; Morine Y; Utsunomiya T; Shimada M
    Anticancer Res; 2017 Oct; 37(10):5877-5883. PubMed ID: 28982915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model.
    Byrne FL; Yang L; Phillips PA; Hansford LM; Fletcher JI; Ormandy CJ; McCarroll JA; Kavallaris M
    Oncogene; 2014 Feb; 33(7):882-90. PubMed ID: 23396365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules.
    Li N; Jiang P; Du W; Wu Z; Li C; Qiao M; Yang X; Wu M
    Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12851-6. PubMed ID: 21768358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis.
    Alesi GN; Jin L; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR; Kang S
    Oncogene; 2016 Oct; 35(41):5412-5421. PubMed ID: 27041561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.
    Suzuki K; Watanabe A; Araki K; Yokobori T; Harimoto N; Gantumur D; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Kubo N; Gombodorj N; Nishiyama M; Hosouchi Y; Kuwano H; Shirabe K
    Anticancer Res; 2018 Feb; 38(2):939-944. PubMed ID: 29374725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
    Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
    Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN loss promotes oncogenic function of STMN1 via PI3K/AKT pathway in lung cancer.
    Xun G; Hu W; Li B
    Sci Rep; 2021 Jul; 11(1):14318. PubMed ID: 34253824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.